Ironwood Pharmaceuticals | IRWD - Passività Correnti





Passività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Almirall EUR 350.64M 52.12M 2025-12
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Amarin USD 179.64M 14.82M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Astellas Pharma JPY 1.22T 106.19B 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Charles River Laboratories USD 1.12B 1.57M 2025-12
Coherus Biosciences USD 140.39M 231.91M 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Incyte USD 1.49B 25.52M 2026-03
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Moderna USD 2.4B 408M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
Pacira USD 108.79M 11.8M 2026-03
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12